We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NYT:NYSENew York Times Company (The) Analysis

Data as of 2026-07-05 - not real-time

$73.85

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The New York Times is trading well above its discounted cash‑flow estimate, with the market price roughly double the industry’s average price‑to‑earnings multiple, suggesting a premium valuation. Revenue growth of about 12% YoY and stable profit margins around 13% underline solid operating performance, while a cash‑rich balance sheet (no debt and a healthy cash balance) supports the declared dividend. The board’s recent affirmation of a $0.23 quarterly payout translates to a modest 1.25% yield and a payout ratio near 40%, indicating dividend sustainability. Technicals are mixed: the 20‑day SMA sits just below price, the MACD histogram is positive and the RSI hovers near the midpoint, pointing to a neutral‑to‑slightly‑bullish short‑term bias, and volume is trending upward. However, 30‑day volatility is near 27% and the stock sits close to its identified resistance around $77, limiting immediate upside.
Looking ahead, analysts project upside of roughly 14% versus the DCF fair value, and the consensus target median of $88 implies further room for price appreciation. The company’s diversified digital offerings, strong brand moat, and consistent cash flow generation bolster a longer‑term growth narrative, but the current premium valuation tempers expectations. Investors should weigh the attractive dividend and growth fundamentals against the elevated price and sector‑specific risks before deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Neutral technical trend with slight bullish MACD histogram
  • Recent dividend affirmation supporting income appeal
  • Price approaching identified resistance level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent revenue and earnings growth
  • Sustainable dividend with low payout ratio
  • Upside potential relative to DCF fair value and analyst targets

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong brand moat and diversified digital portfolio
  • Robust cash generation and zero‑debt balance sheet
  • Long‑term earnings growth underpinning dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth12.10%
Profit Margin13.30%
P/E Ratio31.7
ROE19.68%
ROA10.24%
Debt/Equity2.39
P/B Ratio5.9
Op. Cash Flow$577.6M
Free Cash Flow$390.8M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI51.7
Support$68.52
Resistance$77.04
MA 20$72.87
MA 50$75.54
MA 200$70.73
MACDBullish
VolumeIncreasing
Fear & Greed Index93.2

Valuation

Fair Value$56.55
Target Price$84.11
Upside/Downside13.89%
GradeOvervalued
TypeGrowth
Dividend Yield1.25%

Risk Assessment

Beta0.21
Volatility26.89%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.